Matches in Wikidata for { <http://www.wikidata.org/entity/Q46721125> ?p ?o ?g. }
- Q46721125 description "2008 nî lūn-bûn" @default.
- Q46721125 description "2008年の論文" @default.
- Q46721125 description "2008年学术文章" @default.
- Q46721125 description "2008年学术文章" @default.
- Q46721125 description "2008年学术文章" @default.
- Q46721125 description "2008年学术文章" @default.
- Q46721125 description "2008年学术文章" @default.
- Q46721125 description "2008年学术文章" @default.
- Q46721125 description "2008年學術文章" @default.
- Q46721125 description "2008年學術文章" @default.
- Q46721125 description "2008年學術文章" @default.
- Q46721125 description "2008年學術文章" @default.
- Q46721125 description "2008年學術文章" @default.
- Q46721125 description "2008년 논문" @default.
- Q46721125 description "article científic" @default.
- Q46721125 description "article scientific" @default.
- Q46721125 description "article scientifique" @default.
- Q46721125 description "articol științific" @default.
- Q46721125 description "articolo scientifico" @default.
- Q46721125 description "artigo científico" @default.
- Q46721125 description "artigo científico" @default.
- Q46721125 description "artigo científico" @default.
- Q46721125 description "artikel ilmiah" @default.
- Q46721125 description "artikull shkencor" @default.
- Q46721125 description "artikulong pang-agham" @default.
- Q46721125 description "artykuł naukowy" @default.
- Q46721125 description "artículo científico publicado en 2008" @default.
- Q46721125 description "artículu científicu" @default.
- Q46721125 description "bilimsel makale" @default.
- Q46721125 description "bài báo khoa học" @default.
- Q46721125 description "naučni članak" @default.
- Q46721125 description "scienca artikolo" @default.
- Q46721125 description "scientific article published in March 2008" @default.
- Q46721125 description "scientific article published in March 2008" @default.
- Q46721125 description "scientific article published in March 2008" @default.
- Q46721125 description "teaduslik artikkel" @default.
- Q46721125 description "tieteellinen artikkeli" @default.
- Q46721125 description "tudományos cikk" @default.
- Q46721125 description "vedecký článok" @default.
- Q46721125 description "vetenskaplig artikel" @default.
- Q46721125 description "videnskabelig artikel" @default.
- Q46721125 description "vitenskapelig artikkel" @default.
- Q46721125 description "vitskapeleg artikkel" @default.
- Q46721125 description "vědecký článek" @default.
- Q46721125 description "wetenschappelijk artikel" @default.
- Q46721125 description "wissenschaftlicher Artikel" @default.
- Q46721125 description "επιστημονικό άρθρο" @default.
- Q46721125 description "мақолаи илмӣ" @default.
- Q46721125 description "наукова стаття, опублікована в березні 2008" @default.
- Q46721125 description "научна статия" @default.
- Q46721125 description "научная статья" @default.
- Q46721125 description "научни чланак" @default.
- Q46721125 description "научни чланак" @default.
- Q46721125 description "מאמר מדעי" @default.
- Q46721125 description "مقالة علمية نشرت في مارس 2008" @default.
- Q46721125 description "মার্চ ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46721125 description "บทความทางวิทยาศาสตร์" @default.
- Q46721125 description "სამეცნიერო სტატია" @default.
- Q46721125 name "Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia" @default.
- Q46721125 name "Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia" @default.
- Q46721125 type Item @default.
- Q46721125 label "Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia" @default.
- Q46721125 label "Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia" @default.
- Q46721125 prefLabel "Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia" @default.
- Q46721125 prefLabel "Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia" @default.
- Q46721125 P1433 Q46721125-00489FDA-58BE-4F58-878F-DBEDFC3193C2 @default.
- Q46721125 P1476 Q46721125-83EBFDE4-6458-46A5-BA33-BC80C5B40B8C @default.
- Q46721125 P2093 Q46721125-0239F570-77C0-4BD4-8464-EEABBA7973B3 @default.
- Q46721125 P2093 Q46721125-0800214F-B4F6-4A28-B55B-0966D02E863C @default.
- Q46721125 P2093 Q46721125-1390FC7F-C711-4850-AA45-507EF143D407 @default.
- Q46721125 P2093 Q46721125-2FABDE75-E270-48D4-8AD5-EB50A8943F41 @default.
- Q46721125 P2093 Q46721125-40A785E2-CB0B-443D-861D-60995C0C7730 @default.
- Q46721125 P2093 Q46721125-599B97A0-74B1-42A0-AFE1-DD7109B19C82 @default.
- Q46721125 P2093 Q46721125-66CE7253-2E06-4C6F-B2FF-82B6D77BB206 @default.
- Q46721125 P2093 Q46721125-6D8EEC37-688B-459D-B4C9-AAB3C645B35D @default.
- Q46721125 P2093 Q46721125-7AD60751-F98E-4E1B-8B76-C1849F8F1E2F @default.
- Q46721125 P2093 Q46721125-AAADC013-6138-488D-9E5B-9CA8C88558C6 @default.
- Q46721125 P2093 Q46721125-AB346D59-315E-4FBD-A054-0577D3025E60 @default.
- Q46721125 P2093 Q46721125-B64E886E-F400-464E-ABCF-DD57A85652CA @default.
- Q46721125 P2093 Q46721125-B8C8D340-4BDD-4902-8C9F-89F42542346B @default.
- Q46721125 P2093 Q46721125-D034D5BE-194E-4ECA-B2BA-37B70015E97B @default.
- Q46721125 P2093 Q46721125-D87AF859-8B3C-487D-AFB6-6F6E42BF8DB7 @default.
- Q46721125 P2093 Q46721125-E8C5DEB1-921E-4ABA-9069-DEBF37A2F9AD @default.
- Q46721125 P304 Q46721125-9C35FAB5-5687-4C49-9E8F-E9DF81AE5832 @default.
- Q46721125 P31 Q46721125-CD7286E6-37B9-4D76-AB42-410742B439EC @default.
- Q46721125 P356 Q46721125-1A68E877-0F14-4F6C-9ECD-2412A8F6CF93 @default.
- Q46721125 P407 Q46721125-3E080EDE-6DF0-48BD-817F-39D8995462C2 @default.
- Q46721125 P433 Q46721125-9BB35644-A7AD-4C55-B319-95E20242E60A @default.
- Q46721125 P478 Q46721125-7F1E36F3-5D1D-4B49-8ACE-9DF48C8588A1 @default.
- Q46721125 P50 Q46721125-31B7663E-E2B2-435E-877C-E6A17CA3CCE5 @default.
- Q46721125 P577 Q46721125-41D5C352-04C9-4369-AE82-D3FAB6E52604 @default.
- Q46721125 P698 Q46721125-16E45709-D52D-4380-85C0-E5AFCC96D9CA @default.
- Q46721125 P921 Q46721125-4DD5874C-D474-4EC2-9E9A-1BDC5E75A2A6 @default.
- Q46721125 P921 Q46721125-7AE2C16C-FDE3-4805-9BDD-538612F251BA @default.
- Q46721125 P921 Q46721125-B244D778-8680-4766-A1E8-E5653FA0BA66 @default.
- Q46721125 P921 Q46721125-FDA7AC49-F76A-4E28-A719-B1B0E46FD80B @default.
- Q46721125 P356 1078-0432.CCR-07-4626 @default.
- Q46721125 P698 18316568 @default.
- Q46721125 P1433 Q332253 @default.
- Q46721125 P1476 "Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia" @default.